The debate over assisted dying is nothing new. It’s a topic that has surfaced repeatedly, yet the context in which it’s being discussed today feels particularly troubling. As the UK Parliament prepares to vote on an assisted dying bill, I can’t help but feel that this discussion is happening at the wrong time and under the wrong circumstances.
The pandemic has left a profound and lasting impact on public health. Excess deaths remain elevated, younger individuals are reporting higher rates of illness and disability, and governments are struggling financially. In this context, introducing assisted dying legislation feels less like a step toward compassionate care and more like a troubling response to an overwhelmed healthcare system.
What’s Driving This Shift?
Since the pandemic, we’ve seen a global trend toward legalizing assisted dying and euthanasia. Countries like Canada, Spain, and Switzerland have well-established frameworks, and now the UK seems poised to follow suit. On the surface, this might appear to be a progressive step toward respecting individual autonomy.
Sign up for Preorder and preview here >
However, there’s another side to this story; one that involves the long-term effects of COVID-19 and its treatments. For years, I’ve studied the immune system’s response to the spike protein, whether from the virus or vaccines. The immune priming caused by repeated exposures has set the stage for a wave of chronic illnesses, from heart failure to inflammatory bowel disease, many of which we’re only beginning to understand.
This isn’t speculation; it’s a logical extrapolation of the science. Autoimmune responses triggered by the spike protein don’t follow a predictable path. They can target the heart, kidneys, brain, or gut, leading to a wide array of illnesses that leave patients struggling without clear diagnoses or effective treatments.
Why Timing Is Everything
The timing of the UK’s assisted dying bill is particularly concerning. We’re at a point where healthcare systems are overwhelmed, and governments are grappling with limited resources. Introducing assisted dying now risks creating a system where financial and logistical pressures subtly influence decisions.
For clinicians, the implications are profound. If this bill passes, they will be the ones tasked with assessing patients and making life-or-death decisions. While the bill proposes safeguards, such as requiring two doctors to agree on a case, this system leaves clinicians vulnerable to pressure and burnout.
In my view, if assisted dying is to be introduced, it must be done within the framework of a robust palliative care system. Palliative care teams, trained to address the complex needs of terminally ill patients, should be the ones overseeing these decisions - not individual doctors operating under immense strain.
COVID-19, Autoimmunity, and the Assisted Dying Debate
What makes this moment particularly troubling is the looming impact of COVID-19 complications. Many patients presenting with severe, unexplained symptoms today fall into a gray area. They are chronically ill but not terminal. These are the individuals most vulnerable to the unintended consequences of assisted dying laws.
In Canada, we’ve already seen cases where euthanasia was offered to patients suffering from vaccine-related complications. This precedent raises serious ethical questions. How do we ensure that assisted dying remains a choice and not a solution to systemic failures in healthcare?
The reality is that our understanding of post-COVID illness is still evolving. Introducing assisted dying legislation without fully grasping the scope of these complications risks normalizing it as an easy solution rather than investing in the research and treatments needed to improve lives.
Find out more about the ROOT approach here >
A Call for Leadership and Action
We are at a crossroads. As Parliament debates this bill, I urge policymakers and clinicians to consider the broader implications. Assisted dying is a deeply personal and ethical issue, but its introduction must not come at the expense of addressing the root causes of illness and suffering.
Here’s what I believe needs to happen:
Invest in Palliative Care: Build and fund multidisciplinary palliative care teams to provide comprehensive support for terminally ill patients.
Focus on Research: Commit resources to studying the long-term impacts of COVID-19 and its treatments, particularly autoimmune complications.
Protect Clinicians: Ensure that doctors are not placed in untenable positions by creating systems that share the responsibility and provide safeguards.
Engage the Public: Open a transparent dialogue about the ethical and practical challenges of assisted dying in a post-pandemic world.
Final Thoughts
The assisted dying debate is about more than autonomy - it’s about the kind of society we want to build in the wake of the pandemic. Do we prioritize compassion and care, or do we take shortcuts that address symptoms but ignore underlying issues?
I’m not opposed to the concept of assisted dying, but I believe this is the wrong time to implement it. We owe it to ourselves and future generations to address these challenges with the seriousness and care they deserve.
Please support my research efforts by subscribing to Vejon Health Substack. Your support allows me to continue bringing you my insights in a timely and effective way.
Share this post